Pharmafile Logo
Pharmafocus logo
Advanced Search

prostate cancer

Showing 10 posts of 85 posts found.

Sanofi

Sanofi launches Jevtana in UK

July 6, 2011
Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …

News

Prostate cancer drug Zytiga gains US approval

May 5, 2011
Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer

Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …

News

GSK withdraws applications for Avodart

March 25, 2011
Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …

News
Sanofi-Aventis HQ

Sanofi prostate cancer drug Jevtana approved in Europe

March 21, 2011
Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer

Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …

News

Late-stage blow to AstraZeneca’s prostate cancer drug

February 7, 2011
Research and Development AstraZeneca, Cancer, prostate cancer, zibotentan

A late-stage trial of AstraZeneca’s oral prostate cancer drug zibotentan has been halted after it failed to meet its primary …

News

Success in pre-clinical microRNA treatment of prostate cancer

January 19, 2011
Research and Development MD Anderson Cancer Center, MicroRNA, Mirna Therapeutics, RNA interfering, miRNA, prostate cancer, rnai

A new MicroRNA treatment for prostate cancer has been highly effective against the disease in pre-clinical studies. MicroRNAs, or miRNAs, …

News

Bavarian Nordic courting cancer vaccine backers

November 12, 2010
Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

News

Late stage cancer drug failure for AstraZeneca

September 27, 2010
Sales and Marketing AstraZeneca, prostate cancer, zibotentan

AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …

News

US approval for Sanofi’s Jevtana

July 19, 2010
Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer

US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …

News
NHS Direct

Digital Pharma: NHS Direct pilots online treatment aids

June 11, 2010
Medical Communications NHS, NHS Direct, osteoporosis, patient information, prostate cancer

NHS Direct is piloting online decision aids to help patients suffering from osteoporosis or prostate cancer make informed healthcare choices. …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023